Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001190725-18-000037
Filing Date
2018-11-16
Accepted
2018-11-16 16:31:31
Documents
1
Period of Report
2018-11-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 11815
  Complete submission text file 0001190725-18-000037.txt   13328
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XOMA LTD 2910 SEVENTH ST. BERKELEY CA 94710
Business Address
VAN NESS W DENMAN (Reporting) CIK: 0001221676 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14710 | Film No.: 181190183